These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 2524706

  • 1. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
    MacPhail LA, Greenspan D, Schiødt M, Drennan DP, Mills J.
    Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
    [Abstract] [Full Text] [Related]

  • 2. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Erlich KS, Jacobson MA, Koehler JE, Follansbee SE, Drennan DP, Gooze L, Safrin S, Mills J.
    Ann Intern Med; 1989 May 01; 110(9):710-3. PubMed ID: 2522751
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J.
    N Engl J Med; 1991 Aug 22; 325(8):551-5. PubMed ID: 1649971
    [Abstract] [Full Text] [Related]

  • 4. Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
    Stellbrink HJ, Albrecht H, Löning T, Greten H.
    Klin Wochenschr; 1991 Apr 04; 69(6):274-8. PubMed ID: 1828096
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA, Miller CH, Schrager LE, Crumpacker CS.
    N Engl J Med; 1989 Feb 02; 320(5):297-300. PubMed ID: 2536137
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
    Lateef F, Don PC, Kaufmann M, White SM, Weinberg JM.
    Arch Dermatol; 1998 Sep 02; 134(9):1169-70. PubMed ID: 9762047
    [No Abstract] [Full Text] [Related]

  • 8. Foscarnet effective in acyclovir-resistant herpes.
    Am Pharm; 1991 Nov 02; NS31(11):12. PubMed ID: 1836936
    [No Abstract] [Full Text] [Related]

  • 9. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
    Marks GL, Nolan PE, Erlich KS, Ellis MN.
    Rev Infect Dis; 1989 Nov 02; 11(3):474-6. PubMed ID: 2546244
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
    Jansen CL, Maris-Tegeler WG, Wertheim-van Dillen PM, Frissen PH, Weiland HT, van der Noordaa J.
    Ned Tijdschr Geneeskd; 1992 Feb 08; 136(6):280-4. PubMed ID: 1311058
    [Abstract] [Full Text] [Related]

  • 12. Acyclovir-resistant herpes in AIDS treated with foscarnet.
    Youle MM, Hawkins DA, Collins P, Shanson DC, Evans R, Oliver N, Lawrence A.
    Lancet; 1988 Aug 06; 2(8606):341-2. PubMed ID: 2899762
    [No Abstract] [Full Text] [Related]

  • 13. Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient.
    Bevilacqua F, Marcello A, Toni M, Zavattoni M, Cusini M, Zerboni R, Gerna G, Palù G.
    J Acquir Immune Defic Syndr (1988); 1991 Aug 06; 4(10):967-9. PubMed ID: 1832460
    [Abstract] [Full Text] [Related]

  • 14. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
    Safrin S, Assaykeen T, Follansbee S, Mills J.
    J Infect Dis; 1990 Jun 06; 161(6):1078-84. PubMed ID: 2161035
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
    Birch CJ, Tyssen DP, Tachedjian G, Doherty R, Hayes K, Mijch A, Lucas CR.
    J Infect Dis; 1992 Jul 06; 166(1):108-12. PubMed ID: 1318909
    [Abstract] [Full Text] [Related]

  • 18. [Aciclovir-resistant herpes simplex virus infection in an immuno-depressed patient. Favourable effect of foscarnet].
    Charmot G, Ingrand D, Simon F, Kernbaum S, Fegueux S, De Truchis P, Coulaud JP.
    Presse Med; 1990 Dec 01; 19(41):1905-6. PubMed ID: 2148390
    [No Abstract] [Full Text] [Related]

  • 19. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
    Sall RK, Kauffman CL, Levy CS.
    Arch Dermatol; 1989 Nov 01; 125(11):1548-50. PubMed ID: 2554819
    [Abstract] [Full Text] [Related]

  • 20. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A, Ericson AC, Sohl-Akerlund A, Datema R.
    J Gen Virol; 1988 Jun 01; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.